Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ALNFL.PA
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.23
N/A
-0.20
vs -0.26
Q2.24
N/A
-0.08
vs -0.28
Q4.24
N/A
-0.14
vs -0.20
Sales Growth
YoY
Current
Estimates
Q4.23
NA
NA vs NA
Q2.24
NA
NA vs NA
Q4.24
NA
NA vs NA
Return on Equity
QoQ
Q2.22
-48%
-0.48
vs 3.1
Q4.22
-163%
-1.63
vs -0.48
Q2.23
-111%
-1.11
vs -1.63
Q4.23
-467%
-4.67
vs -1.11
Q2.24
-32%
-0.32
vs -4.67
Q4.24
-138%
-1.38
vs -0.32
Institutionnal Ownership
Forecast
NaN%2025-Revenue
-114%2025-EPS
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.
PAR
Unprofitable
Unprofitable
0.02Â ( 1.74%)
Relative Strenght
Volume Buzz
-78%
Earning Acce
No
Dist 52w H.
64%Relative Strength
ALNFL.PA
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ALNFL.PA compares to sector?